A chimeric influenza virus vaccine expressing fusion protein epitopes induces protection from human metapneumovirus challenge in mice.

Front Microbiol · 2022 · PMC10753001 · PMID 38155756

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Compared with the PBS control group, the low-dose group showed significant neutralizing antibody potency after prime immunization ( p < 0.01), and both the high-dose group after prime immunization and the low and high-dose groups after booster immunization showed highly significant neutralizing antibody potency ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.